| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibody-Drug Conjugates in Prostate Cancer: Where Are we?
|
Mjaess, Georges
|
|
|
21 |
1 |
p. 171-174
|
artikel
|
| 2 |
Assessment of Tolerability, Response and Complications of Concurrent Chemoradiation With Capecitabine and Cisplatin in Muscle-Invasive Bladder Cancer; A Single Arm Study
|
Soltanzadeh, Sara
|
|
|
21 |
1 |
p. 105.e1-105.e6
|
artikel
|
| 3 |
A Systematic Review of Published Clinical Trials in the Systemic Treatment of Adrenocortical Carcinoma: An Initiative Led on Behalf of the Global Society of Rare Genitourinary Tumors
|
Padua, Tiago Costa de
|
|
|
21 |
1 |
p. 1-7
|
artikel
|
| 4 |
Avelumab Maintenance Treatment After First-line Chemotherapy in Advanced Urothelial Carcinoma–A Cost-Effectiveness Analysis
|
Lin, Dong
|
|
|
21 |
1 |
p. 8-15
|
artikel
|
| 5 |
CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)
|
Navani, Vishal
|
|
|
21 |
1 |
p. 106.e1-106.e8
|
artikel
|
| 6 |
Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma
|
Shayeb, Akram M.
|
|
|
21 |
1 |
p. 55-62
|
artikel
|
| 7 |
Development of a Pocket Nomogram to Predict Cancer and Disease Specific Survival After Radical Cystectomy For Bladder Cancer: The CRAB Nomogram
|
Cicione, Antonio
|
|
|
21 |
1 |
p. 108-114
|
artikel
|
| 8 |
Distinct Profiles of DNA Repair Activity Define Favorable-risk Prostate Cancer Subtypes With Divergent Outcome
|
Swami, Nishwant
|
|
|
21 |
1 |
p. 76-83
|
artikel
|
| 9 |
DNA Methylation Architecture Provides Insight into the Pathogenesis of Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis
|
Lin, Yifei
|
|
|
21 |
1 |
p. 32-42
|
artikel
|
| 10 |
Does the Time to Start First-Line Treatment Influence the Survival of Favorable-Risk Patients With Metastatic Renal Cell Carcinoma? Results of the MetaSurv–UroCCR 79 Study
|
Rolley, Cyrielle
|
|
|
21 |
1 |
p. 194-202
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
21 |
1 |
p. A1
|
artikel
|
| 12 |
External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database
|
Yekedüz, Emre
|
|
|
21 |
1 |
p. 175-182
|
artikel
|
| 13 |
Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors
|
Chawla, Neal S.
|
|
|
21 |
1 |
p. 69-75
|
artikel
|
| 14 |
Health-related Quality of Life of Patients Treated With Different Fractionation Schedules for Early Prostate Cancer Compared to the Age-standardized General Male Population
|
Reinikainen, Petri
|
|
|
21 |
1 |
p. 146-154
|
artikel
|
| 15 |
Impact of Body Mass Index on Outcomes in an Asian population of Advanced Renal Cell Carcinoma and Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors
|
Ishihara, Hiroki
|
|
|
21 |
1 |
p. 136-145
|
artikel
|
| 16 |
Management of Localized T1c Prostate Cancer Among Men 75 Years and Older: A National Cancer Database Study
|
Gleicher, Stephanie
|
|
|
21 |
1 |
p. 16-23
|
artikel
|
| 17 |
Modern Active Surveillance in Prostate Cancer: A Narrative Review
|
Pattenden, Trent A
|
|
|
21 |
1 |
p. 115-123
|
artikel
|
| 18 |
Multimodal Management of Testicular Mesothelioma - A Retrospective Analysis From a Tertiary Cancer Care Centre
|
Rathinasamy, Narmadha
|
|
|
21 |
1 |
p. 124-127
|
artikel
|
| 19 |
Natural History of Patients with Prostate MRI Likert 1-3 and Development of RosCaP: a Multivariate Risk Score for Clinically Significant Cancer
|
Orecchia, Luca
|
|
|
21 |
1 |
p. 162-170
|
artikel
|
| 20 |
Perioperative Morbidity of Radical Prostatectomy After Intensive Neoadjuvant Androgen Blockade in Men With High-Risk Prostate Cancer: Results of Phase II Trial Compared to a Control Group
|
Ilario, Eder N.
|
|
|
21 |
1 |
p. 43-54
|
artikel
|
| 21 |
Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy
|
Terbuch, Angelika
|
|
|
21 |
1 |
p. 24-31
|
artikel
|
| 22 |
Prognostic Role of Long-Chain Acyl-Coenzyme A Synthetase Family Genes in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Bioinformatics Analysis Confirmed with External Validation Cohorts
|
Temiz, Mustafa Zafer
|
|
|
21 |
1 |
p. 91-104
|
artikel
|
| 23 |
Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden
|
Stattin, Pär
|
|
|
21 |
1 |
p. 107.e1-107.e9
|
artikel
|
| 24 |
Renal Sarcoma: A Population-Based Study
|
Alevizakos, Michail
|
|
|
21 |
1 |
p. 155-161
|
artikel
|
| 25 |
Review of Toxicities of PARP Inhibitors in Metastatic Castrate Resistant Prostate Cancer
|
Nindra, Udit
|
|
|
21 |
1 |
p. 183-193
|
artikel
|
| 26 |
Site-Specific Differences in PD-1 Blockade Success and Biomarkers in Urothelial Carcinoma Treated with Pembrolizumab
|
Umeda, Kota
|
|
|
21 |
1 |
p. 128-135
|
artikel
|
| 27 |
Table of contents
|
|
|
|
21 |
1 |
p. A2-A6
|
artikel
|
| 28 |
The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade
|
Taheri, Diana
|
|
|
21 |
1 |
p. 84-90
|
artikel
|
| 29 |
The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage Analysis
|
Tully, Karl H.
|
|
|
21 |
1 |
p. 63-68
|
artikel
|
Tijdschrift beschrijving